Pangaea Biotech Overview

  • Founded
  • 2007
Founded
  • Status
  • Public
  • Employees
  • 51
Employees
  • Stock Symbol
  • PANG
Stock Symbol
  • Share Price
  • $1.90
  • (As of Monday Closing)

Pangaea Biotech General Information

Description

Pangaea Oncology SA is a medical services company. The company provides a wide range of services to cancer patients, as well as global pharmaceutical and biotech clients, in the fields of molecular diagnostics, clinical trials, in vitro drug profiling, dx platform validation, and biomarker discovery. The company has aggregated its operations into two segments, Clinical Care division and Diagnostic and Research and Development services division. Clinical Care division delivers medical oncology services and related activities. Diagnostic and Research and Development services division provides diagnostic and in-vitro services.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Drug Discovery
Stock Exchange
XMAD
Primary Office
  • C/Sabino Arana, 5-19
  • 08028 Barcelona
  • Spain
+34 935 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pangaea Biotech Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.90 $1.91 $1.14 - $1.99 $24.9M 3.71K -$0.14

Pangaea Biotech Financials Summary

In Thousands,
USD
TTM 30-Jun-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017 FY 2016 31-Dec-2016
EV 32,736 34,466 31,662
Revenue 3,409 3,609 2,957 2,785
EBITDA 1,166 872 (1,025) (258)
Net Income (1,798) (1,478) (1,857) (658)
Total Assets 20,944 23,282 22,742 18,866
Total Debt 4,963 5,441 5,416 3,743
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pangaea Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pangaea Biotech‘s full profile, request access.

Request a free trial

Pangaea Biotech Executive Team (3)

Name Title Board Seat Contact Info
Javier Rivela Co-Founder & Chief Executive Officer
Rafael Rosell Ph.D Co-Founder, Chief Scientific Officer, Chairman & Member of Scientific Committee
Santiago Ramon y Cajal MD Co-Founder, Vice-President & Director, Molecular Pathology
To view Pangaea Biotech’s complete executive team members history, request access »

Pangaea Biotech Board Members (5)

Name Representing Role Since
000ú0 00000 000é000 Pangaea Biotech Board Member 000 0000
0000 0000000 00 Pangaea Biotech Board Member 000 0000
000000 0ó000-00é0000 Pangaea Biotech Board Member 000 0000
000000 000000 00.0 Pangaea Biotech Co-Founder, Chief Scientific Officer, Chairman & Member of Scientific Committee 000 0000
00000000 00000 0 00000 00 Pangaea Biotech Co-Founder, Vice-President & Director, Molecular Pathology 000 0000
To view Pangaea Biotech’s complete board members history, request access »

Pangaea Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial